Targeting PDGF-CC as a promising therapeutic strategy to inhibit cholangiocarcinoma progression
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Targeting PDGF-CC as a promising therapeutic strategy to inhibit cholangiocarcinoma progression ; volume:22 ; number:1 ; day:14 ; month:11 ; year:2024 ; pages:1-16 ; date:12.2024
Journal of translational medicine ; 22, Heft 1 (14.11.2024), 1-16, 12.2024
- Urheber
-
Luo, Zhenchao
Zhou, Fangfang
Tan, Canliang
Yin, Liangchun
Bao, Man
He, Xiang
Li, Haohui
Yan, Jian
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-024-05857-6
- URN
-
urn:nbn:de:101:1-2502040951456.031129647266
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Luo, Zhenchao
- Zhou, Fangfang
- Tan, Canliang
- Yin, Liangchun
- Bao, Man
- He, Xiang
- Li, Haohui
- Yan, Jian
- SpringerLink (Online service)
Ähnliche Objekte (12)
Biological responses to PDGF-AA versus PDGF-CC in renal fibroblasts
Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke
Osteoclasts control osteoblast chemotaxis via PDGF-BB/PDGF receptor beta signaling
Serum levels of PDGF-CC as a potential biomarker for the diagnosis of Kawasaki disease
Cholangiocarcinoma
Immunhistochemischer Nachweis von PDGF B, PDGF-β-Rezeptoren [PDGF-beta-Rezeptoren] und IGF-I-Rezeptoren während der Atherogenese beim Menschen
A new promising oncogenic target (p.C382R) for treatment with pemigatinib in patients with cholangiocarcinoma
Functionalized graphene oxide as a nanocarrier for multiple suppressive miRNAs to inhibit human intrahepatic cholangiocarcinoma
Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood–brain barrier
Targeting folliculin to selectively inhibit mTORC1: a promising strategy for treating nonalcoholic fatty liver disease
The effect of combined PDGF-B and PDGF-C deficiency on mouse development and brain vasculature
Expression, Lokalisation und funktionelle Bedeutung von PDGF und PDGF-Rezeptoren in der Hypophyse und in Hypophysentumorzellen
Biological responses to PDGF-AA versus PDGF-CC in renal fibroblasts
Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke
Osteoclasts control osteoblast chemotaxis via PDGF-BB/PDGF receptor beta signaling
Serum levels of PDGF-CC as a potential biomarker for the diagnosis of Kawasaki disease
Cholangiocarcinoma
Immunhistochemischer Nachweis von PDGF B, PDGF-β-Rezeptoren [PDGF-beta-Rezeptoren] und IGF-I-Rezeptoren während der Atherogenese beim Menschen
A new promising oncogenic target (p.C382R) for treatment with pemigatinib in patients with cholangiocarcinoma
Functionalized graphene oxide as a nanocarrier for multiple suppressive miRNAs to inhibit human intrahepatic cholangiocarcinoma
Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood–brain barrier
Targeting folliculin to selectively inhibit mTORC1: a promising strategy for treating nonalcoholic fatty liver disease
The effect of combined PDGF-B and PDGF-C deficiency on mouse development and brain vasculature
Expression, Lokalisation und funktionelle Bedeutung von PDGF und PDGF-Rezeptoren in der Hypophyse und in Hypophysentumorzellen
Biological responses to PDGF-AA versus PDGF-CC in renal fibroblasts
Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke
Osteoclasts control osteoblast chemotaxis via PDGF-BB/PDGF receptor beta signaling
Serum levels of PDGF-CC as a potential biomarker for the diagnosis of Kawasaki disease
Cholangiocarcinoma
Immunhistochemischer Nachweis von PDGF B, PDGF-β-Rezeptoren [PDGF-beta-Rezeptoren] und IGF-I-Rezeptoren während der Atherogenese beim Menschen
A new promising oncogenic target (p.C382R) for treatment with pemigatinib in patients with cholangiocarcinoma
Functionalized graphene oxide as a nanocarrier for multiple suppressive miRNAs to inhibit human intrahepatic cholangiocarcinoma
Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood–brain barrier
Targeting folliculin to selectively inhibit mTORC1: a promising strategy for treating nonalcoholic fatty liver disease
The effect of combined PDGF-B and PDGF-C deficiency on mouse development and brain vasculature